Riabni

Active Ingredient(s): Rituximab-arrx
FDA Approved: * December 17, 2020
Pharm Company: * AMGEN INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Riabni Overview

Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer.[9] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[9][10][11][12] It ...

Read more Riabni Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rituximab

Recent Riabni Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Rituximab-arrx
  • Injection: 100mg, 100mg/10ml(10mg/ml), 10mg/ml, 500mg, 500mg/50ml(10mg/ml)
  • Solution: 100mg/10ml (10mg/ml), 500mg/50ml (10mg/ml)
  • Vial: 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Riabni: (2 results)

Sorted by National Drug Code
  • 55513-224 Riabni 100 mg/10ml Intravenous Injection, Solution by Amgen Inc
  • 55513-326 Riabni 500 mg/50ml Intravenous Injection, Solution by Amgen Inc

Other drugs which contain Rituximab-arrx or a similar ingredient: (7 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 August 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA